Richard Bund Sells 690,290 Shares of Microba Life Sciences (ASX:MAP) Stock

Microba Life Sciences Limited (ASX:MAP) insider Richard Bund sold 690,290 shares of the company’s stock in a transaction on Wednesday, September 17th. The shares were sold at an average price of A$0.08, for a total value of A$56,603.78.

Microba Life Sciences Price Performance

The company has a debt-to-equity ratio of 3.84, a current ratio of 2.61 and a quick ratio of 6.50. The firm has a market cap of $116.44 million, a price-to-earnings ratio of -4.53 and a beta of 2.81.

About Microba Life Sciences

Microba Life Sciences Limited provides microbiome testing and analysis services for clinicians, consumers, and research customers in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, and Singapore. The company operates through two segments, Testing Services, and Research and Development.